Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

NCT00112931 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

462

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
OTHER: No treatment

Sponsor

University College, London

Collaborators

[object Object]
[object Object]